Holen Sie sich die Stockscreener-App
312.26
1.42%
-4.22
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SYK?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$316.48
Offen:
$314.52
24-Stunden-Volumen:
1.77M
Relative Volume:
0.78
Marktkapitalisierung:
$119.65B
Einnahmen:
$25.27B
Nettoeinkommen (Verlust:
$3.34B
KGV:
36.17
EPS:
8.6334
Netto-Cashflow:
$4.57B
1W Leistung:
-1.81%
1M Leistung:
-4.74%
6M Leistung:
-16.20%
1J Leistung:
-17.16%
1-Tages-Spanne:
$310.35
$315.69
1-Wochen-Bereich:
$310.35
$322.87
52-Wochen-Spanne:
$281.00
$404.14
Stryker Corp Stock (SYK) Company Profile
Firmenname
Stryker Corp
Sektor
Branche
Telefon
(269) 385-2600
Adresse
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
312.11 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
ABT
Abbott Laboratories
|
86.67 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
MDT
Medtronic Plc
|
77.83 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.84 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.75 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-13 | Eingeleitet | Leerink Partners | Outperform |
| 2026-02-20 | Eingeleitet | William Blair | Outperform |
| 2026-01-27 | Fortgesetzt | TD Cowen | Hold |
| 2026-01-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-12-19 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-09-18 | Eingeleitet | Rothschild & Co Redburn | Neutral |
| 2025-02-26 | Fortgesetzt | Citigroup | Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Outperform |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-22 | Hochstufung | Needham | Hold → Buy |
| 2024-01-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-25 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-28 | Hochstufung | Edward Jones | Hold → Buy |
| 2022-07-21 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-07-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-13 | Eingeleitet | Truist | Hold |
| 2022-03-16 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-07-28 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Underweight |
| 2020-10-06 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-04-01 | Herabstufung | Goldman | Buy → Sell |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Hold |
| 2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | Bestätigt | BTIG Research | Buy |
| 2019-11-05 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-30 | Bestätigt | BofA/Merrill | Buy |
| 2019-07-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-30 | Bestätigt | Canaccord Genuity | Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2019-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-08-16 | Eingeleitet | BTIG Research | Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-04-27 | Bestätigt | Stifel | Buy |
Alle ansehen
Stryker Corp Aktie (SYK) Neueste Nachrichten
Bronstein, Gewirtz & Grossman, LLC Is Investigating Stryker Corporation (SYK) And Encourages Shareholders to Connect - ACCESS Newswire
Barclays Cuts PT on Stryker Corporation (SYK), Calls Q1 Results Mixed - Insider Monkey
Jefferies Financial Group Inc. Boosts Stock Holdings in Stryker Corporation $SYK - MarketBeat
Clearstead Advisors LLC Grows Stake in Stryker Corporation $SYK - MarketBeat
New Stryker bone plates designed to simplify fracture surgery in Europe - Stock Titan
Stryker Launches Pangea Plating System and Completes First Case in Europe – Company Announcement - Financial Times
Legal & General Group Plc Buys 62,817 Shares of Stryker Corporation $SYK - MarketBeat
Stryker Corporation $SYK Shares Sold by Clearstead Trust LLC - MarketBeat
Stryker Corp at Citigroup Inc Unplugged Medtech and Life Sciences Access Day Transcript - GuruFocus
Stryker Corp. stock underperforms Friday when compared to competitors - MSN
Fideuram Intesa Sanpaolo Private Banking S.P.A. Makes New Investment in Stryker Corporation $SYK - MarketBeat
SYK News | STRYKER CORP (NYSE:SYK) - ChartMill
Stryker’s chief accounting officer to retire - MedTech Dive
Stryker stock (US8636671013): medtech leader updates investors after latest quarterly results - AD HOC NEWS
Stryker Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Stryker Corporation (SYK) Announces Leadership Transition in Acc - GuruFocus
Stericycle Inc stock (US8636671013): new CEO and strategic review keep investors alert - AD HOC NEWS
Stryker Corp. stock (US8636671013): Growth story continues after strong results - AD HOC NEWS
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Stryker (SYK) appoints Emily Baculik CAO as Berry shifts to advisor - Stock Titan
PNC Financial Services Group Inc. Lowers Stock Position in Stryker Corporation $SYK - MarketBeat
Stryker Corporation $SYK Stock Position Increased by Atle Fund Management AB - MarketBeat
Stryker: Investors May Have Overreacted To Q1 Weakness (NYSE:SYK) - Seeking Alpha
Is Wall Street Bullish or Bearish on Stryker Corporation Stock? - Yahoo Finance
Stryker Corp. stock (US8636671013): growth story continues after strong recent results and M&A move - AD HOC NEWS
Stryker Corp. stock (US8636671013): acquisition news and medical device growth story - AD HOC NEWS
Stryker Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Stryker’s SWOT analysis: medical device stock shows robust growth in robotics - Investing.com
Stryker’s $835 Million AVS Deal Highlights Growing Role of Michigan’s Medtech Development Pipeline - citybiz
Resona Asset Management Co. Ltd. Trims Stock Holdings in Stryker Corporation $SYK - MarketBeat
Stryker (SYK) Acquires Amplitude Vascular Systems for Up to $835M - GuruFocus
Michigan medtech startup draws $835M Stryker buyout deal - Stock Titan
Stryker Corporation $SYK Shares Bought by AMF Tjanstepension AB - MarketBeat
Stericycle stock (US8636671013): turnaround story gains focus after latest earnings and outlook upda - AD HOC NEWS
Stryker restores most manufacturing after hack damaged networks - MSN
Stryker Corp. stock (US8636671013): earnings momentum and hospital demand keep medical device giant - AD HOC NEWS
Bronstein, Gewirtz & Grossman, LLC Is Investigating Stryker Corporation (SYK) And Encourages Investors to Connect - ACCESS Newswire
Stryker Corp (NYSE:SYK) Passes the Caviar Cruise Quality Screen - ChartMill
Stryker Corp. stock (US8636671013): quarterly results keep medical device demand in focus - AD HOC NEWS
SYK Technical Analysis | Trend, Signals & Chart Patterns | STRYKER CORP (NYSE:SYK) - ChartMill
Stryker stock (US8636671013): Results and product momentum remain in focus - AD HOC NEWS
Stericycle stock (US8636671013): restructuring progress and earnings in focus - AD HOC NEWS
Thrivent Financial for Lutherans Increases Position in Stryker Corporation $SYK - MarketBeat
Dana Investment Advisors Inc. Sells 6,037 Shares of Stryker Corporation $SYK - MarketBeat
Stryker Corp. Hits New 52-Week Low at USD 284.98 - Markets Mojo
Is There Now An Opportunity In Stryker (SYK) After Recent Share Price Pullback - Yahoo Finance
The Robotic Spine Institute of Las Vegas Announces Dr. Kornelis Poelstra’s Completion of 2,000 Robotic Spine Surgeries - GlobeNewswire Inc.
Stryker stock (US8636671013): Medical-device demand stays in focus after fresh company news - AD HOC NEWS
Stryker Corp. stock (US8636671013): Analyst target cut meets upbeat Wall Street outlook - AD HOC NEWS
Surgical Robotics Meets AI: Intuitive Surgical, Medtronic, and Stryker Are the Sleeper Plays of the Healthcare Boom - 24/7 Wall St.
Is Stryker Corporation (SYK) Under Pressure? Truist Lowers Outlook but Keeps Hold Rating - Insider Monkey
Finanzdaten der Stryker Corp-Aktie (SYK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.28%
1.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):